Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation

Digestive Diseases and Sciences

Volumn 53, Issue 2, 2008, Pages 443-450

  Hernando Harder, Ana Cristina ^a   Von Bünau, Rudolf ^b   Nadarajah, Mahaluxmy ^a   Singer, Manfred Vincenz ^a   Harder, Hermann ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Ardeypharm GmbH   (Germany)

Author keywords

Abdominal bloating; Abdominal symptoms; E. coli strain Nissle 1917; Intestinal gas dynamics; Probiotics

Indexed keywords

ESCHERICHIA COLI STRAIN NISSLE 1917; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL STRAIN; BLOATING; CLINICAL FEATURE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION HABIT; DIARRHEA; DIETARY INTAKE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; ENTERITIS; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; FLATULENCE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; IRRITABLE COLON; MALE; METEORISM; NAUSEA AND VOMITING; PAIN ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT INDICATION;

ABDOMEN; ADULT; DEFECATION; DIET; DOUBLE-BLIND METHOD; ESCHERICHIA COLI; FEMALE; FLATULENCE; GASES; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINES; MALE; MIDDLE AGED; PROBIOTICS;

EID: 38649096301     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9892-3     Document Type: Article

References (29)

1. Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512-519
2. Schrezenmeir J, de Vrese M (2001) Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 73:361S-364S
3. Gionchetti P, Lammers KM, Rizzello F, Campieri M (2005) VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol Clin North Am 34:499-513, ix-x
4. Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, Tambasco R, Calabrese C, Campieri M (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306-3313
5. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617-1623
6. Resta-Lenert S, Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988-997
7. Seksik P, Marteau P (2004) Probiotics in inflammatory bowel disease: controlled trials and perspectives. Therapie 59:83-87
8. Vanderhoof JA (2000) Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr 30(Suppl 2):S34-S38
9. Blum G, Marre R, Hacker J (1995) Properties of Escherichia coli strains of serotype O6. Infection 23:234-236
10. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853-858
11. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635-639
12. Henker J, Blokhin B, Bolbot YK, Maydannik VG, Jores L, Wolff C, Schulze J (1917) Successfull therapy of unspecific prolonged diarhoea in infants, toddlers with the probiotic E. coli strain Nissle Gastroenterology 130(4):A-315
13. Henker J, Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, Wolff C, Schulze J (2007) The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 166:311-318
14. Krammer HJ, Kamper H, von Bunau R, Zieseniss E, Stange C, Schlieger F, Clever I, Schulze J (2006) Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3807 patients. Z Gastroenterol 44:651-656
15. Serra J, Azpiroz F, Malagelada JR (1998) Intestinal gas dynamics and tolerance in humans. Gastroenterology 115:542-550
16. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17:895-904
17. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95:1231-1238
18. Mollenbrink M, Bruckschen E (1994) Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor). Med Klin (Munich) 89:587-593
19. Levitt MD, Furne J, Olsson S (1996) The relation of passage of gas and abdominal bloating to colonic gas production. Ann Intern Med 124:422-424
20. Niedzielin K, Kordecki H, Birkenfeld B (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13:1143-1147
21. Serra J, Azpiroz F, Malagelada JR (2001) Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol Gastrointest Liver Physiol 281:G138-G143
22. Serra J, Azpiroz F, Malagelada JR (2001) Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 48:14-19
23. Harder H, Serra J, Azpiroz F, Passos MC, Aguade S, Malagelada JR (2003) Intestinal gas distribution determines abdominal symptoms. Gut 52:1708-1713
24. Harder H, Serra J, Azpiroz F, Malagelada JR (2004) Reflex control of intestinal gas dynamics and tolerance in humans. Am J Physiol Gastrointest Liver Physiol 286:G89-G94
25. Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ (2006) Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 131:1003-1010
26. Azpiroz F, Malagelada JR (2005) The pathogenesis of bloating and visible distension in irritable bowel syndrome. Gastroenterol Clin North Am 34:257-269
27. Azpiroz F, Malagelada JR (2005) Abdominal bloating. Gastroenterology 129:1060-1078
28. Azpiroz F, Serra J (2004) Treatment of excessive intestinal gas. Curr Treat Options Gastroenterol 7:299-305
29. Levitt MD (1975) Intestinal gas. Postgrad Med 57:77-81